Introduction
Ractopamine HCl is a β-adrenergic leanness-enhancing agent that has gained regulatory approval for use in market swine in the United States (FDA, 2000a) . To date, ractopamine has not been approved for use in other species, and such use would be considered off- 1 The technical assistance of D. Ellig, J. Giddings, G. Harrington, S. Hoff, and J. Radunz is gratefully acknowledged.
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tively. Sheep liver residues after a 7-d withdrawal period were less than the limit of quantification (2.5 ppb). Sheep kidney residues were 65.1 and undetectable at 0-and at 3-and 7-d, withdrawal periods, respectively. Cattle liver residues were 9.3, 2.5, and undetectable after 0-, 3-, and 7-d withdrawal periods, respectively; kidney residues were 97.5, 3.4, and undetectable at the same respective withdrawal periods. Concentrations of parent ractopamine in sheep urine were 9.8 ± 3.3 ppb on withdrawal d 0 and were below the LOQ (5 ppb) beyond the 2-d withdrawal period. After the hydrolysis of conjugates, ractopamine concentrations were 5,272 ± 1,361 ppb on withdrawal d 0 and 178 ± 78 ppb on withdrawal d 7. Ractopamine concentrations in cattle urine ranged from 164 ± 61.7 ng/mL (withdrawal d 0) to below the LOQ (50 ppb) on withdrawal d 4. After the hydrolysis of conjugates in cattle urine, ractopamine concentrations were 4,129 ± 2,351 ppb (withdrawal d 0) to below the LOQ (withdrawal d 6). These data indicate that after the hydrolysis of conjugates, ractopamine should be detectable in urine of sheep as long as 7 d after the last exposure to ractopamine and as long as 5 d after withdrawal in cattle.
label. In Europe, a ban on the use of β-adrenergic agents exists (Council of European Communities, 1986) . In the United States, reports of illegal or off-label use of β-agonists have been restricted to show animals (Mitchell and Dunnavan, 1998) . Such is not the case in Europe and Asia where several instances of clenbuterol-mediated food poisonings have occurred (Anonymous, 1998; Kuiper et al., 1998; Brambilla et al., 2000) . In the United States, illicit β-agonist use by humans hoping to improve their phenotypic appearance has been documented (Prather et al., 1995; Hausmann et al., 1998) .
The detection of ractopamine use is of interest to governmental regulatory officials, importers and(or) exporters, and organizers of livestock shows and(or) racing events (horses and dogs). To this end, Shelver et al. (2000) have developed a sensitive monoclonal antibody based enzyme-linked immunosorbant assay (ELISA) for ractopamine. The assay has potential application for the detection of ractopamine residues in show animals, market animals and tissues, performance animals, and humans. Tissue levels of ractopamine in target animals have only been reported in abstract form (FDA, 2000b) and have not been reported for nontarget animals. Therefore, the objective of this study was to determine the residue levels of ractopamine HCl in tissues of ducks, sheep, and cattle and in urine of cattle and sheep after administration of 20 (cattle, sheep) or 30 ppm (ducks) dietary ractopamine HCl (Paylean). Incurred residues in tissues and urine were also used to validate the usefulness of the ELISA developed by Shelver et al. (2000) ; these data will be reported in a separate communication.
Materials and Methods
Ducks. White Pekin ducklings were purchased from Townline Hatchery (Zeeland, MI) and were placed into a floor pen covered with wood shavings. Pens were equipped with electric heating lights placed approximately 40 cm above the floor to ensure adequate heating. Ducklings had ad libitum access to Start and Grow poultry ration (Table 1 ; Purina Mills; St. Louis, MO) for 10 d. Thereafter, ducks were given ad libitum access to Duck Grower ration (Purina Mills) . At approximately 6 wk of age (2.5 ± 0.2 kg) ducks were provided individual identification numbers (leg band) and ad libitum access to feed containing 30 ppm ractopamine HCl. Prior to exposure to ractopamine-containing feed, six untreated ducks were selected and slaughtered for collection of control tissues. The remaining ducks were allowed access to dietary ractopamine for seven consecutive days.
Seven-day feeding periods were chosen for ducks (as well as other species) because the U.S. FDA generally considers a 7-d feeding period adequate to bring tissue residues to steady state for residue depletion studies (FDA, 1994) . Total residues of ractopamine have been demonstrated to achieve steady-state concentrations after a 4-d feeding period in swine (Dalidowicz et al., 1992) , but in the absence of such data for ducks, sheep, and cattle, the longer feeding period was considered to be more appropriate. Six ractopamine-treated ducks each were slaughtered after practical 0-(within 6 h of last exposure to feed; FDA, 1994), 3-, and 7-d withdrawal periods. The commercial grower diet, unfortified with Paylean, was fed during the withdrawal period.
Sheep. Three wethers and three ewes were purchased from the North Dakota State University sheep center, were tagged, and were adapted to the Biosciences Research Laboratory barn facilities for a 2-wk period. Sheep were housed by sex in concrete-floored stalls (10.0 m 2 ) covered with wood shavings. During the adaptation period, all sheep were given ad libitum access to hay and water and each pen was provided with 2.1 kg of a grain concentrate (Table 2) twice daily (at about 0730 and 1630). Ractopamine-containing diets (20 ppm; ∼0.373 mg/kg BW ractopamine per day) were fed to sheep (75.7 ± 8.4 kg) over 8 d in 14 meals of 2.1 kg per pen (0.7 kg per sheep). Sheep were fed the initial ractopamine-containing meal at the afternoon feeding (T 0 ); the last feeding of ractopamine-fortified feed was on T 7 /W 0 at the morning feeding. A wether and ewe were each euthanatized on T 7 /W 0 , W 3 , and W 7 (0-, 3-, and 7-d withdrawal periods, respectively and water and were fed grain concentrate (0.7 kg/animal) twice daily. Starting the day prior to feeding the ractopaminefortified diets and continuing throughout the feeding and withdrawal periods, urine was collected from each sheep. On T 0 , urine was collected prior to the initial exposure to feed containing ractopamine. On the following days urine was collected between about 1300 and 1400 h and was stored at −20°C until analysis.
Cattle. Six crossbred beef heifers were purchased at a local auction and were housed at the North Dakota State University beef facilities for approximately 60 d while being halter-broken; during this period they were given ad libitum access to hay and water. Heifers were transferred to the Biosciences Research Laboratory, ear-tagged, and were adapted to a concentrate diet (Table 2). The allotment of concentrate was increased from 0.45 to 6.81 kg/d over a 29-d period. Animals were provided concentrate at approximately 0730 h daily and each animal received 6.8 kg for 7 d prior to treatment with ractopamine. Heifers (315 ± 21 kg) were provided 6.8 kg of concentrate containing 20 ppm ractopamine (∼0.432 mg/kg BW ractopamine/d) for eight consecutive days and had ad libitum access to hay during the period of concentrate adaptation and during the ractopamine feeding period. Two heifers each were slaughtered after withdrawal periods of 0, 3, and 7 d. Urine was collected daily as described above for sheep.
Diets and Diet Formulation. Paylean (2% ractopamine
HCl premix) was provided by Elanco Animal Health (Greenfield, Indiana). Duck, sheep, and cattle diets were placed into ribbon mixers and appropriate aliquots of Paylean were added to each diet followed by mixing for 10 to 20 min after each addition. Prior to the addition of ractopamine, the pelleted duck ration was mixed with 10 mL/kg of canola oil. The oil was added to reduce the dustiness of the feed and to prevent the Paylean from segregating during mixing. After mixing, duplicate aliquots of each batch of feed were removed for determination of ractopamine concentration by HPLC (described below). Final concentrations of ractopamine in the duck, sheep, and cattle rations were 32.2 ± 1.5, 22.8 ± 1.2, and 18.9 ± 1.8 mg/kg (± SD) respectively.
Feed and Tissue Analysis. Animal feeds and tissues
were assayed for parent ractopamine according to methods AM-AA-CR-J448-AB-791 and B03766, respectively. These methods are the validated regulatory methods for the determination of ractopamine in swine feed and tissues. The methods are available from the Center for Veterinary Medicine's Document Control Unit (HFV-199); FDA, 7500 Standish Place, Rockville, MD 20855). Although the methods were validated for swine feeds and tissues, they were used for all feed and tissue analyses. The only modification to the tissue method was that 2.5-g aliquots of liver and kidneys of ducks were analyzed instead of the 10-g aliquots called for in the method.
Analysis of Parent Ractopamine in Urine Samples.
Ractopamine in cattle and sheep urine samples was quantified by HPLC after sample cleanup using solidphase extraction (SPE). Disposable 3-mL C-18 SPE tubes, packed with 500 mg sorbent (BakerBond, J.T. Baker, Phillipsburg, NJ), were preconditioned with 5 mL of methanol followed by 10 mL of water. Urine samples (1 mL) and vial rinses (1 mL) were pulled through columns with slight vacuum; columns were then rinsed sequentially with 5 mL water, 5 mL water/ methanol (1:1, vol/vol), and ractopamine was eluted with 5 mL of 0.05 M ammonium acetate buffer (pH 4.5)/ methanol (1:1, vol/vol). Buffer/methanol eluents were evaporated to dryness using a centrifugal evaporator (Savaant; Holbrook, NY) and the residue was dissolved in 250 L 0.05 M ammonium acetate, pH 4.5, containing 2% CH 3 CN. Sample aliquots (50 L) were chromatographed with a 3.9 × 150 mm Waters (Milford, MA) Resolve C-18 column (5 m particle size) using an isocratic mobile phase consisting of 0.005 M sodium octanesulfonate (Regis, Morton Grove, IL) in a mixture of water, acetonitrile, and acetic acid (71:27:2). Ractopamine was eluted at a flow rate of 1 mL/min (Waters Model 600 HPLC pump, Waters, Milford, MA) and was detected with a Jasco (Tokyo, Japan) Model FP-920 fluorescence detector set at an excitation wavelength of 226 nm and an emission wavelength of 305 nm. Peak area was collected for ractopamine peaks, and ractopamine concentrations were calculated using regression equations generated from standard curves consisting of points at 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, and 80 ng of ractopamine (on column; standards were 25, 50, 100, 200, 400, 800, and 1,600 ng/mL). Each sample set was prepared with a matrix blank and a fortified matrix blank (consisting of a known quantity of ronide) from which recovery values were calculated. Urine samples from individual animals within day of study were run in duplicate. The limit of quantitation (LOQ) for parent ractopamine in incurred samples was 5 ng/mL (signal:noise ratio of 5).
Enzyme Hydrolysis of Ractopamine Conjugates. Metabolites other than ractopamine sulfate and(or) glucuronic acid conjugates have not been identified in animals treated with ractopamine (Dalidowicz et al., 1992; Smith et al., 1993; Smith et al., 1995) . As a result, ractopamine excreted in urine as conjugates was measured after hydrolysis with β-glucuronidase/aryl sulfatase from Patella vulgata (Sigma, St. Louis, MO). Glucuronidase from Patella vulgata was chosen only after a series of experiments established it as an appropriate enzyme source. Briefly, glucuronidases from E. coli, Helix pomatia, Patella vulgata, and bovine liver (all from Sigma) were each tested for their ability to hydrolyze synthetic [ 14 C]ractopamine glucuronides (Smith et al., 1993) fortified into control sheep urine.
For these experiments, approximately 2.6 g of ractopamine-glucuronide was fortified into 1 mL of control sheep urine, 1-mL aliquots of buffers were added (pH 6.8 for E. coli; pH 6.0 for bovine liver; pH 5.0 for Helix pomatia and Patella vulgata) according to the manufacturer's instructions, enzyme (50 units from E. coli; 4,500 units from Helix pomatia; 5,000 units from Patella vulgata and bovine liver) was added, and incubations (37°C) were run overnight. Hydrolysis of [ 14 C]ractopamine glucuronide was determined as recovery of radiocarbon after SPE as described above. All experiments were run with control incubations in which urine was replaced with ultrapure water. Enzyme from Patella vulgata efficiently (94.3%) hydrolyzed ractopamine glucuronide and incubations were subsequently optimized for incubation length, pH, and mass of ractopamine glucuronide present (Figure 1) .
Analysis of Urinary Ractopamine After Hydrolysis of
Conjugates. Duplicate 1-mL urine samples were mixed with 1 mL of 1.0 M ammonium acetate buffer (pH 5.0), and 50 L of glucuronidase/arylsulfatase (5,000 Fishman Units) from Patella vulgata were added to each tube. Tubes were incubated overnight (14 to 16 h) using a shaking water bath (50 rpm; 37°C). For each analysis, control urine was fortified with a known amount of synthetic [ 14 C]ractopamine glucuronide of known specific activity.
Hydrolysis of ractopamine conjugates in urine samples caused the release of materials that interfered with the chromatographic quantitation of parent ractopamine using the purification procedures described for the extraction of parent ractopamine from unhydrolyzed urine. In order to remove the interferences a solvent extraction step was added to the purification procedure. Enzyme hydrolyses were terminated by the addition of 2 mL of 2 M sodium carbonate. Aliquots (2 mL) of ethyl acetate were added to each tube, samples were rotated slowly (∼8 rpm) on a sample mixer (ATR, Inc., Laurel, MD) for 5 min followed by centrifugation at 3,000 × g for 10 min, and the ethyl acetate layer was removed. Extractions were repeated using sequential 2-and 4-mL aliquots of ethyl acetate. Ethyl acetate fractions for individual samples were combined and evaporated to dryness using a centrifugal evaporator, and the dry residue was reconstituted in 4 mL of 0.05 M HCl. Solidphase extraction tubes (C18, described above) were conditioned as described above, but the extraction sequence was altered as follows: Aqueous acid samples were loaded onto SPE columns, columns were rinsed sequentially with 5 mL of water, 2.5 mL of water methanol (1:1, vol/vol); 2.5 mL of 100% methanol, and ractopamine was eluted with 5 mL of 0.05 M ammonium acetate buffer (pH 4.5)/methanol (1:1; vol/vol). Buffer/methanol fractions were evaporated to dryness using a centrifugal evaporator and were reconstituted in 1.0 mL of 0.05 M ammonium acetate (pH 4.5) buffer containing 2% CH 3 CN prior to chromatographic analysis. Sample extracts were chromatographed as described for parent ractopamine (unhydrolyzed samples) with the exception that a Waters 4.6 × 250 mm Symmetry column (5 m) was used in the place of the Waters Resolve column. Ractopamine concentrations were determined by linear regression using a standard curve consisting of points at 2.5, 5, 10, 20, 40, 80, and 160 ng on column corresponding to standard solutions of 50, 100, 200, 400, 800, 1600, and 3200 ng/mL. The LOQ for the enzyme hydrolysis assay was 50 ng/mL of urine.
Blank matrix, and matrix samples fortified with 1,028 to 1,159 ng of [ 14 C]ractopamine glucuronide (ractopamine HCl equivalents), were run with each sample set so that analyte recovery could be calculated. The exact amount of [ 14 C]ractopamine glucuronide added was determined by liquid scintillation counting (LSC) of quintuplicate aliquots of the glucuronide standard solution.
Results
Tissue Residues. Table 3 shows the residues of parent ractopamine in livers and kidneys of ducks, sheep, and cattle. Because few animals were used, no statistical inferences are appropriate between species within a withdrawal period. Figures 2 and 3 , respectively, show representative chromatograms of sheep and cattle urine samples carried through the enzymatic hydrolysis and purification procedures. Extracts of hydrolyzed control urine samples (panels C of Figures 2 and 3) were free of interferences. Chromatograms from urine extracts of cattle did not differ substantially from those of sheep. Concentrations of ractopamine before and after the hydrolysis of conjugates in urine of sheep are shown in Table 4 . Table 5 shows the elimination of ractopamine and conjugated metabolites in beef urine. A graphical comparison of the excretion of unconjugated ractopamine present in sheep and cattle urine is shown in Figure 4 . 
Discussion
Residues of parent ractopamine were numerically greater in kidneys of cattle and sheep than in liver, but depleted rapidly from both tissues. Residues were not detectable in duck liver and kidney, possibly because 2.5-g rather than 10.0-g samples were analyzed. Attempts to liberate ractopamine conjugates in tissues via enzymatic hydrolysis caused the release of numerous compounds that were not removed by the tissue analytical method (data not shown) and interfered with the chromatographic analysis of ractopamine. Doerge et al. (2001) , however, determined ractopamine residues in the same cattle and sheep liver samples by liquid chromatography/ mass spectrometry (LC/MS/MS) after enzymatic hydrolysis. Residues after a 0-d withdrawal period averaged 63.7 and 76.5 ppb (after enzyme hydrolysis) in sheep and cattle, respectively. These results suggest that parent ractopamine represented approximately 38 and 12% of the "total" ractopamine residue (parent and metabolites) in sheep and cattle liver, respectively, at zero withdrawal. These data are commensurate with the percentage of total radioactive residues present as parent ractopamine in swine (27% FDA, 2000b) slaughtered with a 0-d withdrawal period, and are also consistent with the percentage of total residues comprised of ractopamine in livers of dogs and rats (Dalidowicz et al., 1992) .
Residues in eyes of these animals were not measured in our laboratory, but were measured by Doerge et al. (2001) using LC/MS/MS in the selected ion mode. Ractopamine accumulated in eyes, but not nearly to the extent that clenbuterol accumulates in ocular tissues; ractopamine residues in retinal epithelium of cattle ranged The purpose of collecting urine was to determine whether urinary ractopamine residues and(or) ractopamine metabolites might serve as a useful screening agent for determining animal exposure to ractopamine.
Off-label use of ractopamine has been a concern for organizers of livestock shows and racing events. Our data indicate that the excretion of parent ractopamine in cattle is of sufficient magnitude to easily detect its use concurrently with feeding. If animals are provided unfortified feed, levels of parent ractopamine in urine fall 14 C]ractopamine glucuronide hydrolyzed with glucuronidase from Patella vulgata, and extracted as described in the Materials and Methods section; (C) a hydrolyzed and extracted blank cow urine sample; and (D) a hydrolyzed urine sample from a cow allowed dietary ractopamine HCl. The peak height of the fortified sample extract is less than that shown for the sheep sample (Figure 2 ) because only 20 L was of the extract was injected.
rapidly, but are detectable to about the 7th day of withdrawal in sheep and to about the 5th day of withdrawal in cattle. Hydrolysis of ractopamine metabolites may or may not extend the period in which ractopamine is detected in cattle. In sheep, parent ractopamine was not always detectable during the ractopamine feeding period but was easily detected throughout the feeding and 7-d withdrawal periods after hydrolysis of conjugates. After hydrolysis, residues averaged 178 ± 78 ppb in urine of sheep 7 d after exposure to ractopamine. Mean of three animals; three animals had residues below the limit of quantification.
f Mean of five animals; one animal had residues below the limit of quantification.
g Value for one animal; remaining animals had residues below the limit of quantification.
h Urine from one sheep was not collected.
i Mean of three animals; one animal had residues below the limit of quantification. Although the LOQ for tissues, unhydrolyzed urine samples, and hydrolyzed urine samples in this study were 2.5, 5, and 50 ppb, respectively, several techniques could be used to improve these sensitivities. By improving assay sensitivity, the time period after the last exposure to ractopamine could be extended significantly. First, the use of a more sensitive fluorescence detector could improve the LOQ to perhaps 1 ppb for tissues and urine. Second, the LOQ of the hydrolyzed urine samples could be improved by solvating the final sample in 250 l rather than the 1 mL used in our analysis. Third, a larger initial volume of urine could be used for the analysis. We used 1-mL samples in our analyses, but the solid-phase and liquid extractions could easily accommodate larger sample volumes. Probably the best methods for improving sensitivities, while retaining excellent selectivity, would be with the use of LC/MS/MS systems or with an immunoassay. Thus, the potential exists for analytical techniques that will allow the detection of ractopamine residues in excreta of cattle or sheep for over 1 wk after their last exposure to Paylean.
Recoveries of ractopamine in control urine samples fortified with ractopamine or ractopamine-glucuronides averaged nearly 100% for ractopamine and ractopamine glucuronide fortified into sheep urine samples (enzyme assay). Ractopamine and ractopamine glucuronide reference standards were carbon-14-labeled and the mass added to recovery samples was based on the specific activity of each compound. Masses of ractopamine recovered were calculated from chromatographic peak areas and regression equations generated from standard curves (r 2 = 0.999 ± 0.003). Standard curves were generated by gravimetrically measuring the mass of ractopamine HCl, but the mass of ractopamine or ractopamine glucuronide added to recovery standards was based on the specific activity of each compound. Nonradioactive ractopamine glucuronide standards were not available in quantities that would allow for accurate gravimetric measurement. Because specific activities of the parent ractopamine was fairly low (1,072 dpm/g; 1 dpm/ng), and because about 1 g of ractopamine was added to recovery standards, the addition of ractopamine to recovery samples, based on radioactivity estimates, probably underestimated the amount of ractopamine actually added. As a result, absolute recoveries are probably slightly overestimated. In preliminary experiments, recoveries of radiocarbon when added as a mixture of [
14 C]ractopamine and [ 14 C]ractopamine glucuronide and carried through the hydrolysis and extraction procedures was 94.3 ± 3.4% (n = 4), so absolute recoveries of ractopamine were still excellent.
Implications
Cattle and sheep excrete detectable residues of ractopamine and(or) metabolites in urine 5 to 7 d after their last exposure to dietary ractopamine. The use of immunologically or mass spectrally based detection techniques would likely extend the time after the last exposure to ractopamine that it could be measured in urine. This study demonstrates that detection of ractopamine use in live cattle and sheep is possible even after exposure of animals to ractopamine has been discontinued.
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